# Diagnosis of Colorectal Cancer and Advanced Adenoma Using Cancer-specific Methylation Signatures

> **NCT03828396** · — · UNKNOWN · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 1300 (estimated)

## Conditions studied

- Colorectal Cancer
- Advanced Adenoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03828396
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-10-26
- **Primary completion:** 2019-09-30
- **Final completion:** 2020-09-30
- **Target enrollment:** 1300 (ESTIMATED)
- **Last updated:** 2019-02-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03828396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03828396, "Diagnosis of Colorectal Cancer and Advanced Adenoma Using Cancer-specific Methylation Signatures". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03828396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*